Status:
COMPLETED
Investigations on Differences in Atorvastatin Metabolites Ratios as a Diagnostic Tool in Detecting Atorvastatin Induced Myotoxicity
Lead Sponsor:
University of Oslo School of Pharmacy
Conditions:
Myotoxicity of Atorvastatin Treatment
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
The primary objective of the study is to investigate the ratios of p-hydroxyatorvastatin to atorvastatin in patients receiving atorvastatin treatment, who experience muscle adverse events, to elucidat...
Detailed Description
The primary objective of the study is to investigate the ratios of p-hydroxyatorvastatin to atorvastatin in patients receiving atorvastatin treatment, who experience muscle adverse events, to elucidat...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Suspected atorvastatin induced muscle adverse events.
- Signed informed consent.
- 18 years of age or older.
- Able to donate blood samples.
Exclusion
Key Trial Info
Start Date :
May 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2009
Estimated Enrollment :
53 Patients enrolled
Trial Details
Trial ID
NCT00414531
Start Date
May 1 2005
End Date
June 1 2009
Last Update
December 3 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rikshospitalet-Radiumhospitalet HF, Lipid clinic
Oslo, Norway, 0027